Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 16Completed 11Recruiting 10Terminated 6Unknown 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 6

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Gonadotropin-Releasing Hormone × Clear all
NCT02582749 2022-07-11

Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases

Hoosier Cancer Research Network

Phase 2 Terminated
16 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT00103376 2018-11-05

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Medical University of South Carolina

Phase 2 Terminated
23 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT01439542 2018-08-09

FASTR

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Terminated
19 enrolled
Genitourinary

Prostatic Neoplasms

NCT00860158 2018-03-14

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Hoosier Cancer Research Network

Phase 2 Terminated
1 enrolled 3 charts
Genitourinary

Prostatic Neoplasms

NCT03211052 2017-07-07

NEPTUNE

Queen Mary University of London

Phase 2 Terminated
16 enrolled
Genitourinary

Prostatic Neoplasms

NCT00521781 2016-03-17

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

The Methodist Hospital Research Institute

Phase 2 Terminated
14 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡